Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $21
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $19 to $21.
Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $19 to $21.